Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma

被引：27

作者：

Ohmura, Shunya ^{[1
,2
,3
,4
]}

Marchetto, Aruna ^{[4
]}

Orth, Martin F. ^{[4
]}

Li, Jing ^{[1
,2
,3
]}

Jabar, Susanne ^{[5
,6
]}

Ranft, Andreas ^{[5
,6
]}

Vinca, Endrit ^{[1
,2
,3
]}

Ceranski, Katharina ^{[1
,2
,3
]}

Carreno-Gonzalez, Martha J. ^{[1
,2
,3
]}

Romero-Perez, Laura ^{[1
,2
,3
,4
]}

Wehweck, Fabienne S. ^{[4
]}

Musa, Julian ^{[1
,2
,3
,4
,7
]}

Bestvater, Felix ^{[8
]}

Knott, Maximilian M. L. ^{[4
]}

Hoelting, Tilman L. B. ^{[4
]}

Hartmann, Wolfgang ^{[9
]}

Dirksen, Uta ^{[5
,6
]}

Kirchner, Thomas ^{[10
,11
]}

Cidre-Aranaz, Florencia ^{[1
,2
,3
,4
]}

Grunewald, Thomas G. P. ^{[1
,2
,3
,4
,12
]}

机构：

[1] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[2] German Canc Res Ctr, Div Translat Pediat Sarcoma Res B410, Neuenheimer Feld 280, D-69210 Heidelberg, Germany

[3] Hopp Childrens Canc Ctr KiTZ, Neuenheimer Feld 280, D-69210 Heidelberg, Germany

[4] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Max Eder Res Grp Pediat Sarcoma Biol, Munich, Germany

[5] Univ Hosp Essen, West German Canc Ctr, Pediat 3, Essen, Germany

[6] German Canc Consortium DKTK, Partner Site Essen, Essen, Germany

[7] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany

[8] German Canc Consortium DKTK, Light Microscopy Facil, German Canc Res Ctr DKFZ, Heidelberg, Germany

[9] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Div Translat Pathol, Munster, Germany

[10] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany

[11] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany

[12] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany

来源：

MOLECULAR CANCER | 2021年 / 20卷 / 01期

关键词：

Ewing sarcoma; RRM2; Targeted therapy; Prognostic biomarker; Paediatric oncology; Triapine; Chemoresistance; RIBONUCLEOTIDE REDUCTASE INHIBITOR; GTI-2040 PLUS DOCETAXEL; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; PHASE-I/II; MANAGEMENT; RECURRENCE;

D O I：

10.1186/s12943-021-01393-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：7

共 50 条

[31] Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients
A. C. M. van de Luijtgaarden
Y. M. H. Versleijen-Jonkers
M. H. S. Roeffen
H. W. B. Schreuder
U. E. Flucke
W. T. A. van der Graaf
Targeted Oncology, 2013, 8 : 253 - 260
[32] Connecxin 43 May Be a Potential Prognostic Biomarker for Ewing Sarcoma (EWS)/PNET
Bui, M. M.
Pasha, T. L.
Acs, G.
Zhang, P. J.
MODERN PATHOLOGY, 2009, 22 : 12A - 12A
[33] Identification of miR-34a as a prognostic biomarker of Ewing sarcoma family of tumors
Manara, Maria Cristina
Nakatani, Fumihiko
Ventura, Selena
Ferracin, Manuela
Negrini, Massimo
Serra, Massimo
Picci, Piero
Scotlandi, Katia
CANCER RESEARCH, 2011, 71
[34] Connecxin 43 May Be a Potential Prognostic Biomarker for Ewing Sarcoma (EWS)/PNET
Bui, M. M.
Pasha, T. L.
Acs, G.
Zhang, P. J.
LABORATORY INVESTIGATION, 2009, 89 : 12A - 12A
[35] Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target
Town, Jennifer
Pais, Helio
Harrison, Sally
Stead, Lucy F.
Bataille, Carole
Bunjobpol, Wilawan
Zhang, Jing
Rabbitts, Terence H.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (13) : 3603 - 3608
[36] THE RECEPTOR TYROSINE KINASE RON: A THERAPEUTIC TARGET IN METASTATIC EWING SARCOMA?
Schleithoff, C.
Tillmanns, A.
Lechtape, B.
Schaefer, C.
Juergens, H.
Hempel, G.
Dirksen, U.
Potratz, J.
PEDIATRIC BLOOD & CANCER, 2014, 61 : S176 - S176
[37] Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis
Wu, B.
Peng, R.
Chen, Y.
Zhong, J.
Zhong, S.
Wang, B.
Li, X.
Jiang, N.
Shang, J.
Wang, D.
Lu, H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (11) : 2109 - 2118
[38] UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma
Ou, Yuhong
Luo, Hongtao
Zhang, Qiuning
Du, Tianqi
Liu, Ruifeng
Wang, Dandan
Chen, Junru
Dong, Meng
Wang, Yuhang
Yang, Zhen
Wang, Xiaohu
FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (04):
[39] The epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma
Ye, D
Maitra, A
Timmons, CF
Leavey, PJ
Ashfaq, R
Ilaria, RL
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 459 - 466
[40] BRCA1:NRF2 pathway as a new therapeutic target in ewing sarcoma
Bassani, Nicklas
CLINICAL CANCER RESEARCH, 2022, 28 (18)

← 1 2 3 4 5 →